Product Information
VANCOMYCIN 1 GM VIAL is a generic product labeled by Mylan Institutional LLC, priced at $2.9591 per EA under NDC 67457034001. Its NADAC has been published 404 times since May 28, 2014.
FDA first approved this application on Dec 30, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/20mL
Manufacturer
Mylan Institutional LLCNDC
67457034001
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
3/19/2025
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065397FDA Approved
12/30/2008
TE Code
AP
On Market Since
12/5/2013
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN 1 GM VIAL has been published 404 times since May 28, 2014, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9591 per EA |
|---|---|
| All-time high | $13.2420 (Jul 12, 2017) |
| All-time low | $2.5368 (Nov 20, 2024) |
| Median price | $5.7137 |
| Average price | $6.7204 |
| Largest weekly change | -64.5% (Apr 17, 2024) |
| Weeks tracked | 404 |
| Tracking since | May 28, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-66.3%
5Y
-66.3%
All
-28.8%
Last surveyed Apr 16, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vancomycin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Glycopeptide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANCOMYCIN 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN 1 GM VIAL, manufactured by Mylan Institutional LLC, is $2.9591 per EA (NDC 67457034001), effective Apr 16, 2025.
How has the price of VANCOMYCIN 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN 1 GM VIAL has declined 28.8%. It has been tracked across 404 weekly CMS publications since May 28, 2014.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN 1 GM VIAL?
Since May 28, 2014, the NADAC for VANCOMYCIN 1 GM VIAL has ranged from a low of $2.5368 (Nov 20, 2024) to a high of $13.2420 (Jul 12, 2017), with a median of $5.7137 per EA.
Are there cheaper alternatives to VANCOMYCIN 1 GM VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VANCOMYCIN 1 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures VANCOMYCIN 1 GM VIAL?
VANCOMYCIN 1 GM VIAL (NDC 67457034001) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.